ScholarGate
Assistent

Methoden vergleichen

Prüfen Sie die ausgewählten Methoden nebeneinander; abweichende Zeilen sind hervorgehoben.

Instrumentalvariablen-Methode (IV) zur Kausalinferenz×Markov-Modell in der Gesundheitsökonomie×
FachgebietGesundheitsökonomieGesundheitsökonomie
FamilieProcess / pipelineProcess / pipeline
Entstehungsjahr1990s (modern applications)1983
UrheberAngrist & Pischke (applied econometrics); rooted in econometric theoryBeck & Pauker (medical decision analysis, Massachusetts General Hospital)
TypMethodMethod
Wegweisende QuelleAngrist, J. D., & Pischke, J. S. (2009). Mostly Harmless Econometrics: An Empiricist's Companion. Princeton: Princeton University Press. link ↗Beck, J. R., & Pauker, S. G. (1983). The Markov Process in Medical Prognosis. Medical Decision Making, 3(4), 419-458. DOI ↗
AliasnamenIV, two-stage least squares, TSLS, causal estimationMarkov model, state transition model, cohort simulation
Verwandt35
ZusammenfassungInstrumental variables (IV) is an econometric method to estimate causal effects when treatment or exposure is not randomly assigned and confounding is severe or unmeasured. IV relies on a third variable (instrument) that influences treatment but does not directly affect the outcome, allowing researchers to isolate the causal effect from the noise of confounding. Developed extensively in econometrics (Angrist & Pischke, 1990s–2000s), IV methods are increasingly used in health economics and health services research to leverage natural experiments and policy changes.A Markov model is a decision-analytic tool that simulates disease progression through defined health states over time, calculating cumulative costs and quality-adjusted life years (QALYs) to enable cost-effectiveness analysis. Developed by Beck and Pauker in 1983, Markov models are now the standard framework for projecting long-term outcomes of health interventions, especially chronic diseases where patients transition between clinical states (treatment response, disease progression, remission, death). Used by health technology assessment bodies and pharmaceutical companies to predict intervention value beyond trial duration.
ScholarGateDatensatz
  1. v1
  2. 3 Quellen
  3. PUBLISHED
  1. v1
  2. 3 Quellen
  3. PUBLISHED

Zur Suche Folien herunterladen

ScholarGateMethoden vergleichen: Instrumental Variables in Health Research · Markov Model in Health Economics. Abgerufen am 2026-06-20 von https://scholargate.app/de/compare